These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 12998143

  • 21. [Experimental studies on the effect of ganglion blocking agents on acral blood circulation in relation to the degree of sensitization].
    HEIDELMANN G, PETZOLD H.
    Z Gesamte Exp Med; 1952 Apr 18; 118(5):474-82. PubMed ID: 14951462
    [No Abstract] [Full Text] [Related]

  • 22. Do ganglion-blocking agents and reserpine affect central vasomotor activity?
    McCUBBIN JW, PAGE IH.
    Circ Res; 1958 Nov 18; 6(6):816-24. PubMed ID: 13585611
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of ganglion-blocking agents on serum iron].
    POPP A, CZERMAK E.
    Acta Neuroveg (Wien); 1956 Nov 18; 13(2-3):311-6. PubMed ID: 13326337
    [No Abstract] [Full Text] [Related]

  • 24. Neuromuscular and ganglionic blocking action of thiamine and its derivatives.
    DI PALMA JR, HITCHCOCK P.
    Anesthesiology; 1958 Nov 18; 19(6):762-9. PubMed ID: 13595256
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of various ganglion blockers on blood coagulation].
    MAROGNA L.
    G Ital Chir; 1956 Jul 18; 12(7):365-77. PubMed ID: 13366017
    [No Abstract] [Full Text] [Related]

  • 26. The influence of mecamylamine on the action of certain other ganglionic blocking agents.
    PAYNE JP.
    Br J Anaesth; 1957 Aug 18; 29(8):358-62. PubMed ID: 13460132
    [No Abstract] [Full Text] [Related]

  • 27. Studies on cholinergic-blocking substances. VI. The pharmacology of hexamethonium- and pendiomid type ganglionic-blocking compounds.
    GYERMEK L.
    Acta Physiol Acad Sci Hung; 1954 Aug 18; 5(1-2):163-79. PubMed ID: 13147923
    [No Abstract] [Full Text] [Related]

  • 28. [Role of acetylcholine, atropine and ganglion-blocking agents in excitation transmission of vagal stimulation on the intestines].
    WICK H.
    Acta Neuroveg (Wien); 1957 Aug 18; 16(1-4):230-2. PubMed ID: 13520331
    [No Abstract] [Full Text] [Related]

  • 29. The ganglionic blocking activity of a series of 4-aminoethylpiperidine derivatives.
    COLVILLE KI, FANELLI RV.
    J Am Pharm Assoc Am Pharm Assoc; 1956 Nov 18; 45(11):727-9. PubMed ID: 13376360
    [No Abstract] [Full Text] [Related]

  • 30. The comparative effects of four ganglionic blocking agents on the cardiovascular system of man.
    WINSOR T.
    Am J Med Sci; 1955 Aug 18; 230(2):133-42. PubMed ID: 14398691
    [No Abstract] [Full Text] [Related]

  • 31. Effect of the ganglion blocking agent Ciba 9295 (dibromide of N N N' N'-3-pentamethyl-N-N'-diethyl-3-azopentane-1,5 diammonium) on the postaggressive discharge of adrenalin by the adrenal medulla; histophysiology.
    ROMANI JD.
    C R Seances Soc Biol Fil; 1952 Oct 18; 146(19-20):1508-11. PubMed ID: 13020230
    [No Abstract] [Full Text] [Related]

  • 32. Ganglionic blocking activity of bis-trialkylammoniumethyl ether salts and their branched homologues.
    FAKSTORP J, PEDERSEN JG, POULSEN E, SCHILLING M.
    Acta Pharmacol Toxicol (Copenh); 1957 Oct 18; 13(1):52-8. PubMed ID: 13381502
    [No Abstract] [Full Text] [Related]

  • 33. Studies with the ganglionic blocking agent, chlorisondamine chloride in unanesthetized and anesthetized dogs.
    MAXWELL RA, PLUMMER AJ, OSBORNE MW.
    Circ Res; 1956 May 18; 4(3):276-81. PubMed ID: 13317018
    [No Abstract] [Full Text] [Related]

  • 34. Protective effect of ganglionic blocking agents on traumatic shock in the rat.
    ROSS CA, HERCZEG SA.
    Proc Soc Exp Biol Med; 1956 Feb 18; 91(2):196-9. PubMed ID: 13297751
    [No Abstract] [Full Text] [Related]

  • 35. Effect of ganglionic blocking agents on pressor responses induced by splanchnic faradization.
    MAXWELL RA, PLUMMER AJ, ROSS SD, OSBORNE MW.
    Proc Soc Exp Biol Med; 1956 May 18; 92(1):225-7. PubMed ID: 13336124
    [No Abstract] [Full Text] [Related]

  • 36. The influence of certain ganglionic blocking agents on neuromuscular transmission.
    DEACOCK AR, DAVIES TD.
    Br J Anaesth; 1958 May 18; 30(5):217-25. PubMed ID: 13536201
    [No Abstract] [Full Text] [Related]

  • 37. Ganglionic blocking activity of homologues and analogues of bis-choline ether salts.
    FAKSTORP J, PEDERSEN JG.
    Acta Pharmacol Toxicol (Copenh); 1957 May 18; 13(4):359-67. PubMed ID: 13443998
    [No Abstract] [Full Text] [Related]

  • 38. The use of serial carotid occlusion, nictitating membrane and cross-circulation technics in the investigation of the central hypotensive activity of ganglionic blocking agents.
    LAPE HE, HOPPE JO.
    J Pharmacol Exp Ther; 1956 Apr 18; 116(4):453-61. PubMed ID: 13320289
    [No Abstract] [Full Text] [Related]

  • 39. Supersensitivity due to prolonged administration of ganglion-blocking compounds.
    EMMELIN N.
    Br J Pharmacol Chemother; 1959 Jun 18; 14(2):229-33. PubMed ID: 13662579
    [Abstract] [Full Text] [Related]

  • 40. [Effect of ganglion-blocking agents on tissue respiration in the superior cervical ganglion].
    VYSOTSKAIA NB.
    Farmakol Toksikol; 1962 Jun 18; 25():160-3. PubMed ID: 13927013
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.